Theravance Biopharma, Inc. · NASDAQ:TBPH

Newtyn Management, LLC reported a 8.50% stake in Theravance Biopharma, Inc. (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 17, 2026

Newtyn Management, LLC reported a 8.50% stake in Theravance Biopharma, Inc., 4,300,000 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).

Stake
8.50%
Shares
4,300,000
Intent
Passive
What changed
Stake changed
Filed together
2 holders

The filing in full

HolderStakeShares
Newtyn Management, LLC8.50%4,300,000
Newtyn TE Partners, LP5.30%2,678,900

Source

View original at SEC

Related